Lumbosacral Radicular Pain Market Growth Outlook Reveals A CAGR Of 5.7% And A Market Value Of $1.27 Billion By 2030
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Lumbosacral Radicular Pain Market Expansion Outlook: What Revenue Opportunities Lie Ahead?
In recent years, the market for lumbosacral radicular pain has experienced robust expansion. Projected to rise from $0.97 billion in 2025 to $1.02 billion in 2026, this growth reflects a compound annual growth rate (CAGR) of 6.0%. Historical progress has been driven by factors such as an aging demographic, spinal degenerative conditions, use of opioids for pain control, hospital-based pain management clinics, and the volume of orthopedic surgical procedures.
Projections indicate that the lumbosacral radicular pain market will experience robust expansion in the coming years, reaching $1.28 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.7%. This anticipated growth during the forecast period is fueled by the increasing uptake of non-opioid pain therapies, a rise in outpatient pain management procedures, the integration of digital tools for pain monitoring, advancements in minimally invasive spine technologies, and the broadening of rehabilitation programs. Key trends shaping this period include a greater emphasis on multimodal pain management approaches, a surge in interventional spine procedures, heightened demand for treatments that avoid opioids, an expansion of rehabilitation-focused care models, and a growing preference for minimally invasive interventions to address pain.
Download A Free Sample Report For Comprehensive Market Insights:
Lumbosacral Radicular Pain Market Demand Drivers Creating New Revenue Opportunities
The increasing prevalence of degenerative spinal conditions is expected to propel the growth of the lumbosacral radicular pain market going forward. Degenerative spinal conditions refer to a group of disorders caused by the gradual wear and tear of the spine over time. The rise in degenerative spinal conditions is due to aging populations and lifestyle factors that increase the risk of spinal wear and nerve compression, leading to higher demand for diagnosis and treatment. Lumbosacral radicular pain helps identify underlying degenerative spinal conditions by signaling nerve root irritation or compression, guiding clinical evaluation and management. For instance, in May 2023, according to the University of Sydney, an Australia-based public university, it is anticipated that more than 800 million people worldwide will suffer from back discomfort by 2050. Therefore, the increasing prevalence of degenerative spinal conditions drives the growth of the lumbosacral radicular pain market.
Lumbosacral Radicular Pain Market Driver: Rising Prevalence Of Obesity Driving The Market Growth Due To Sedentary Lifestyles And Dietary Changes
The rising prevalence of obesity is expected to propel the growth of the lumbosacral radicular pain market going forward. Obesity refers to a medical condition characterized by excessive body fat accumulation, typically defined as having a body mass index of 30 or higher, which increases the risk of various health complications. The increasing prevalence of obesity is driven by sedentary lifestyles and processed food consumption patterns, as modern work environments increasingly involve prolonged sitting and desk-based activities while convenient access to high-calorie, nutrient-poor foods has become widespread in developed nations. Growing obesity directly supports higher incidence of lower back and leg pain caused by compressed nerve roots, as excess body weight places additional mechanical stress on the lumbar spine and surrounding structures, leading to nerve compression and inflammation. For instance, in May 2025, according to the Office for Health Improvement and Disparities, a UK-based government body, from 2023 to 2024, an estimated 64.5% of adults aged 18 and over in England were overweight or living with obesity, up from 64.0% in 2022 to 2023. Therefore, the rising prevalence of obesity is driving the growth of the lumbosacral radicular pain market.
Lumbosacral Radicular Pain Market Segment Analysis And Revenue Opportunities
The lumbosacral radicular pain market covered in this report is segmented –
1) By Treatment Type: Pharmacological Treatment, Non-Pharmacological Treatment, Interventional Procedures
2) By Route Of Administration: Oral, Topical, Injectable, Implantable
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By End User: Hospitals, Specialty Clinics, Rehabilitation Centers, Homecare Settings
Subsegments:
1) By Pharmacological Treatment: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Anticonvulsants, Antidepressants, Muscle Relaxants, Corticosteroids
2) By Non-Pharmacological Treatment: Physical Therapy, Exercise And Rehabilitation Programs, Chiropractic Care, Acupuncture, Cognitive Behavioral Therapy, Heat And Cold Therapy
3) By Interventional Procedures: Epidural Steroid Injections, Radiofrequency Ablation, Nerve Root Blocks, Spinal Cord Stimulation, Minimally Invasive Decompression, Intrathecal Drug Delivery Systems
Lumbosacral Radicular Pain Market Leading Players Shaping Industry Direction
Major companies operating in the lumbosacral radicular pain market are Medtronic plc, Boston Scientific Corporation, Nevro Corp., SPR Therapeutics, Saluda Medical Pty Ltd., Nalu Medical Inc., Abbott Neuromodulation, Stryker Corporation, Zimmer Biomet Holdings Inc., Globus Medical Inc., NuVasive Inc., Orthofix Medical Inc., B. Braun Melsungen AG, Teleflex Incorporated, Merit Medical Systems Inc., Avanos Medical Inc., Halyard Health Inc., Terumo Corporation, Baxter International Inc., Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Pfizer CentreOne, Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Lupin Limited, Zydus Lifesciences Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals Inc., Perrigo Company plc
Access The Complete Lumbosacral Radicular Pain Market Report:
Lumbosacral Radicular Pain Market Geographic Distribution And Regional Opportunities
North America was the largest region in the lumbosacral radicular pain market in 2025. The regions covered in the lumbosacral radicular pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
